Publication|Articles|November 1, 2024
- November 2024
- Volume 30
- Issue 12
Table Multiple Myeloma Trials November 2024
Author(s)Ryan Flinn, Mary Caffrey
Key Takeaways
Advertisement
TABLE. Multiple Myeloma: Enrollment of Black Patients in Trials Required for Initial FDA Approval
Articles in this issue
about 1 year ago
To Improve Clinical Trial Equity in Multiple Myeloma, Just Askabout 1 year ago
Advancing Equitable Access to Elevate Value-Based Cancer CareNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care
2
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
3
Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19
4
Experts Warn Binge Drinking Drives Early-Onset Breast Cancer, While Cessation Reduces Risk
5










































